|
"wei yu liao"的相關文件
顯示項目 61-70 / 133 (共14頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019-03-04T07:47:57Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Chen, Kuan-Yu;Tsai, Tzu Hsiu;CHONG-JEN YU;JIN-YUAN SHIH;CHAO-CHI HO;WEI-YU LIAO; WEI-YU LIAO; CHAO-CHI HO; Tsai, Tzu Hsiu; Chen, Kuan-Yu; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T07:33:42Z |
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
|
Chang, Gee Chen;Cseh, Agnieszka;Carrière, Philippe;Lorence, Robert M.;Chih-Hsin Yang, James;Unk, Mojca;Spataro, Vito;Gautschi, Oliver;Nechushtan, Hovav;Curioni-Fontecedro, Alessandra;Peters, Solange;WEI-YU LIAO;JIN-YUAN SHIH; Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; JIN-YUAN SHIH; WEI-YU LIAO; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M.; Carri?re, Philippe; Cseh, Agnieszka; Chang, Gee Chen |
| 臺大學術典藏 |
2019-03-04T06:51:46Z |
Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma
|
Yang, Ching-Yao;CHONG-JEN YU;JIN-YUAN SHIH;WEI-YU LIAO;MIN-SHU HSIEH; Yang, Ching-Yao; MIN-SHU HSIEH; WEI-YU LIAO; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T06:50:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang, James Chih Hsin;Lin, Zhong Zhe;Lee, Jih Hsiang;Yang, Ching Yao;Lin, Yen Ting;Chen, Kuan-Yu;CHONG-JEN YU;JIN-YUAN SHIH;CHIA-LIN HSU;CHAO-CHI HO;WEI-YU LIAO;JIN-SHING CHEN; Lin, Yen Ting; JIN-SHING CHEN; WEI-YU LIAO; CHAO-CHI HO; CHIA-LIN HSU; Yang, Ching Yao; Chen, Kuan-Yu; Lee, Jih Hsiang; Lin, Zhong Zhe; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Wei-Yu Liao;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S. |
| 臺大學術典藏 |
2019 |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yu C.-J.; Yang J.C.-H.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yao Z.-H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Yu C.-J. |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:03Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang, W.-C. and Xiao, F. and Shih, J.-Y. and Ho, C.-C. and Chen, Y.-F. and Tseng, H.-M. and Chen, K.-Y. and Liao, W.-Y. and Yu, C.-J. and Yang, J.C.-H. and Kuo, S.-H. and Cheng, J.C.-H. and Yang, P.-C. and Hsu, F.-M.; Chong-Jen Yu; WEI-YU LIAO; FU-REN XIAO; YA-FANG CHEN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:05:26Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao, W.-Y. and Ho, C.-C. and Tsai, T.-H. and Chen, K.-Y. and Shih, J.-Y. and Yu, C.-J.; WEI-YU LIAO |
| 臺大學術典藏 |
2018-09-10T18:05:26Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
WEI-YU LIAO; Chong-Jen Yu; JIN-YUAN SHIH; Ho, C.-C. and Liao, W.-Y. and Lin, C.-A. and Shih, J.-Y. and Yu, C.-J. and Chih-Hsin Yang, J. |
顯示項目 61-70 / 133 (共14頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
|
